Part 11 Gap Assessment
Requirement-by-requirement review of system use, procedures, validation evidence and technical controls.
Identify and close compliance gaps in electronic records, audit trails, electronic signatures, access controls and computerized system validation.
PHARPRO provides founder-led 21 CFR Part 11 consulting in the Middle East for pharmaceutical and life-sciences organizations in Jordan, UAE, Saudi Arabia and wider MENA. Every assessment is tied to intended use, data risk and defensible evidence.
A practical service for new implementations, legacy remediation, pre-inspection reviews and supplier-hosted systems.
Requirement-by-requirement review of system use, procedures, validation evidence and technical controls.
Assess audit-trail generation, review, retention, time stamps, changes and ALCOA+ controls.
Review identity, uniqueness, signature manifestation, record linkage and procedural governance.
Evaluate roles, privileges, account lifecycle, segregation of duties and administrator oversight.
Connect intended use and risk to URS, configuration, testing, traceability and release decisions.
Prioritized actions covering procedures, configuration, validation, supplier evidence and governance.
Suitable for systems that create, modify, maintain, archive, retrieve or transmit regulated electronic records.
Every engagement produces structured, traceable evidence - not just a checklist - that holds up when an FDA or EU GMP inspector asks how each control was verified.
Requirement-by-requirement findings mapped to each system, ranked by compliance and data-integrity risk.
Evidence that audit trails capture the required who/what/when for every regulated record, with gaps flagged individually.
Confirmation that signature manifestation, uniqueness and record linkage meet Part 11 §11.50-§11.70.
Prioritized, dated action plan covering procedures, system configuration, validation evidence and governance - scoped so your team knows what to fix first.
The same founder-led, evidence-first approach used across PHARPRO's CSV and QA engagements: intended use and data risk first, checklist compliance second. A typical assessment runs 2-4 weeks depending on system count and complexity, starting with a remote evidence review before any on-site work is scoped. For system-level validation evidence beyond Part 11 scope, see Computerized System Validation; for wider audit-trail and access-control requirements under EU GMP, see the EU GMP Annex 11 Compliance Checklist.
Electronic records and signatures, audit trails, access, security, procedures, validation, retention and actual operational practices.
Yes. PHARPRO supports remote evidence review and interviews, with onsite work available across the Middle East.
Yes. Findings are prioritized by compliance and data risk with clear actions for configuration, procedures, validation and governance.
Start with a focused fit check and identify the next practical decision for your system or remediation program.
Book a Free Fit CheckElectronic records and signatures, audit trails, user access, security, procedures, validation evidence, retention and operational practices.
Yes. Remote evidence review is available, with onsite support across the Middle East when required.
Validation and appropriate procedural and technical controls are central when regulated organizations rely on electronic systems for GxP records or signatures.